Literature DB >> 3291646

Propofol-nitrous oxide versus thiopental-isoflurane-nitrous oxide for general anesthesia.

V A Doze1, A Shafer, P F White.   

Abstract

One hundred and twenty patients undergoing elective operations were randomly assigned to receive anesthesia with either thiopental, 4 mg/kg-isoflurane, 0.2-3%-nitrous oxide, 60-70% (control) or propofol, 2 mg/kg-propofol infusion, 1-20 mg/min-nitrous oxide, 60-70% (propofol). Although anesthetic conditions were similar during the operation, differences were noted in the recovery characteristics. For non-major (superficial) surgical procedures, the times to awakening, responsiveness, orientation, and ambulation were significantly shorter in the propofol group (4 +/- 3, 5 +/- 4, 6 +/- 4, and 104 +/- 36 min) than in the control group (8 +/- 7, 9 +/- 7, 11 +/- 9, and 142 +/- 61 min, respectively). In addition, less nausea and vomiting (20 vs. 45%) and significantly less psychomotor impairment was noted in the non-major propofol (vs. control) group. Following major abdominal operations, recovery characteristics did not differ between propofol and control groups. Delayed emergence (greater than 20 min), significant psychometric impairment, and a high overall incidence of postoperative side effects (55-60%) were noted in both drug treatment groups. The authors conclude that propofol-nitrous oxide compares favorably to thiopental-isoflurane-nitrous oxide for maintenance of anesthesia during short outpatient procedures. However, for major abdominal operations, propofol anesthesia does not appear to offer any clinically significant advantages over a standard inhalational anesthetic technique.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3291646     DOI: 10.1097/00000542-198807000-00010

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  16 in total

1.  Randomized comparison of outcome after propofol-nitrous oxide or enflurane-nitrous oxide anaesthesia in operations of long duration.

Authors:  K Korttila; P L Ostman; E Faure; J L Apfelbaum; M Ekdawi; M F Roizen
Journal:  Can J Anaesth       Date:  1989-11       Impact factor: 5.063

Review 2.  Recovery room problems or problems in the PACU.

Authors:  D K Rose
Journal:  Can J Anaesth       Date:  1996-05       Impact factor: 5.063

3.  Propofol infusion anaesthesia for caesarean section.

Authors:  M A Gregory; T Gin; G Yau; R K Leung; K Chan; T E Oh
Journal:  Can J Anaesth       Date:  1990-07       Impact factor: 5.063

4.  Comparative evaluation of propofol and thiopentone for total intravenous anaesthesia.

Authors:  H Kashtan; G Edelist; J Mallon; D Kapala
Journal:  Can J Anaesth       Date:  1990-03       Impact factor: 5.063

5.  Respiratory and cardiovascular effects of fentanyl during propofol-induced sedation under spinal anesthesia.

Authors:  Satoru Tanaka; Hideaki Tsuchida; Hajime Sonoda; Akiyoshi Namiki
Journal:  J Anesth       Date:  1998-12       Impact factor: 2.078

6.  Treatment of postoperative nausea and vomiting: comparison of propofol, droperidol and metoclopramide.

Authors:  G Lacroix; M R Lessard; C A Trépanier
Journal:  Can J Anaesth       Date:  1996-02       Impact factor: 5.063

7.  Propofol for pediatric radiotherapy.

Authors:  Jyotsna Punj; Sushma Bhatnagar; Abha Saxena; Seema Mishra; T R Kannan; Manas Panigrahi; Vipin Pandey
Journal:  Indian J Pediatr       Date:  2002-06       Impact factor: 1.967

Review 8.  Propofol. An update of its use in anaesthesia and conscious sedation.

Authors:  H M Bryson; B R Fulton; D Faulds
Journal:  Drugs       Date:  1995-09       Impact factor: 9.546

Review 9.  Practical treatment recommendations for the safe use of anaesthetics.

Authors:  J W Sear
Journal:  Drugs       Date:  1992-01       Impact factor: 9.546

10.  Recovery characteristics following anaesthesia with sevoflurane or propofol in adults undergoing out-patient surgery.

Authors:  C Wandel; S Neff; H Böhrer; A Browne; J Motsch; E Martin
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.